$4450
$3560
The Technetium-99m market size is projected to reach US$ 4.54 billion in 2024 and is expected to reach US$ 6.03 billion by 2031. The Technetium-99m market size is estimated to register a CAGR of 4.2% during 2025–2031.
Technetium-99m Market AnalysisThe Technetium-99m market is growing, with North America having the biggest share because of its strong healthcare systems and high need for imaging. Europe is gradually using more Technetium-99m, while Asia Pacific is growing quickly and is expected to have the highest yearly growth rate. More investment in SPECT technology, better radiopharmaceuticals, and rising needs for medical tests will help more people use Tc-99m around the world.
Technetium-99m Market OverviewTechnetium-99m is the most widely used diagnostic radioisotope in nuclear medicine, valued for its short half-life, low radiation dose to patients, and superior imaging quality. It is critical in SPECT scans for cardiology, oncology, musculoskeletal disease, and monitoring multiple organ function. Its vast clinical applications, as well as the availability of reliable supplies via generator-based production, solidify Technetium as an important tool in medical imaging around the world.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Technetium-99m Market: Strategic Insights
Market Size Value in US$ 4,268.15 million in 2022 Market Size Value by US$ 6,072.86 million by 2030 Growth rate CAGR of 4.5% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Technetium-99m Market Drivers and OpportunitiesCustomize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Technetium-99m Market: Strategic Insights
| Market Size Value in | US$ 4,268.15 million in 2022 |
| Market Size Value by | US$ 6,072.86 million by 2030 |
| Growth rate | CAGR of 4.5% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
- Increasing Need for Accurate and Efficient Diagnostic Imaging: The need for rapid and reliable medical imaging is leading to widespread usage of Technetium-99m across hospitals and diagnostic imaging centers.
- Increasing Frequency of Advanced Hybrid Imaging Systems: The growing use of SPECT/CT and similar combined imaging systems is raising the demand for Technetium-99m medicines.
- Increasing Workflow Efficiency and Decreasing Radiation Dose to Patients: Technetium-99m provides faster, lower-radiation scans that improve imaging efficiency and patients' safety in general.
- Government Support for Diagnostic Infrastructure and Expansion: The healthcare community is funding and implementing policies that promote Technetium-99m-based imaging concepts.
- Improvements in SPECT and Detector Technology: Continued technology advancements and improvements associated with imaging systems will improve the accuracy and clinical value of examining patients with Technetium-99m.
Market Opportunities:
- Expanding Healthcare Infrastructure in Developing Regions: There is an excellent opportunity for Technetium-99m uptake through the expansion of hospitals and diagnostic centres in Africa, Asia, and Latin America.
- Collaborations with Radiopharmaceutical Manufacturers: Working with radiopharmaceutical manufacturers and imaging system providers can improve the Tc-99m solution availiability, availability, quality, and scalability.
- Utilization Alongside Advanced Hybrid Imaging Systems: New hybrid imaging systems (e.g., SPECT and CT, PET, and SPECT) will drive the usage of Technetium-99m radiopharmaceuticals.
- Growing Adoption Among Leading Diagnostic Centres: The increased use of Tc-99m as a routine and specialized diagnostic procedure at hospitals and imaging centres will facilitate the use of Tc-99m radiopharmaceuticals.
- Increasing Global Focus on Early Detection and Prevention of Disease: The move toward preventing illness and better testing will help increase the use of Technetium-99m around the world.
The Technetium-99m market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in industry reports:
By Application:
- Cardiovascular: Technetium-99m is used in myocardial perfusion imaging to assess blood flow, detect ischemia, and evaluate heart function efficiently.
- Bone Scan: Tc-99m helps detect fractures, infections, and bone metastases, offering early diagnosis and thorough skeletal imaging with low radiation exposure.
- Respiratory: Tc-99m aids in lung ventilation and perfusion scans, identifying pulmonary embolism, airway obstruction, and other respiratory disorders accurately.
- Tumor Imaging: Technetium-99m radiopharmaceuticals locate and monitor tumors, assess metastasis, and guide treatment decisions.
- Others: Tc-99m is applied in renal, hepatobiliary, thyroid, and gastrointestinal scans, offering functional assessment and early disease detection.
By End User:
- Hospitals
- Diagnostic and Imaging Centers
- Others
By Geography:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Market Report Scope
Technetium-99m Market Share Analysis by GeographyAsia Pacific is expected to grow the fastest in the next few years. Quick growth in hospitals and clinics, more use of advanced imaging systems, and strong government support for early disease detection are the main reasons. Also, more money going into testing centers and a bigger need for good, fast imaging are helping the Technetium-99m market grow in the region. New markets in Latin America, the Middle East, and Africa give Tc-99m suppliers new chances to grow and help with better testing.
The Technetium-99m market develops differently across regions due to factors such as healthcare infrastructure, nuclear medicine adoption rates, availability of imaging technology, and supportive government healthcare initiatives. Below is a summary of market share and trends by region:
1. North America
- Market Share: Holds a significant portion due to a mature healthcare sector and early adoption of advanced nuclear imaging technologies
- Key Drivers:
- High demand for Tc-99m in cardiology, oncology, and bone diagnostics
- Presence of leading hospitals and nuclear medicine centers
- Government initiatives supporting early disease detection and nuclear medicine programs
- Trends: Expansion of hybrid SPECT/CT imaging and adoption of high-efficiency Tc-99m radiopharmaceuticals
2. Europe
- Market Share: Moderate share with growing use of advanced nuclear medicine systems and emphasis on early diagnostics
- Key Drivers:
- Increasing healthcare investments and an aging population
- Shift toward hybrid and high-resolution imaging modalities
- Supportive regulations promoting preventive healthcare and early diagnosis
- Trends: Growing use of Tc-99m in hybrid imaging, cardiology, and oncology diagnostics
3. Asia Pacific
- Market Share: Expected to grow the fastest due to expanding healthcare infrastructure and rising nuclear imaging adoption
- Key Drivers:
- Rapid expansion of diagnostic centers and hospitals
- Government support for healthcare modernization and early disease detection
- Increasing demand for efficient and accurate imaging procedures
- Trends: Surge in adoption of SPECT/CT systems and Tc-99m radiopharmaceuticals for cardiology, bone, and oncology applications
4. South and Central America
- Market Share: Developing market with rising demand for diagnostic imaging in urban healthcare centers
- Key Drivers:
- Growing awareness of early disease detection
- Increasing investments in nuclear medicine facilities
- Partnerships between local healthcare providers and international suppliers
- Trends: Expansion of Tc-99m usage in routine diagnostics and specialized imaging procedures
5. Middle East and Africa
- Market Share: Emerging market with growing interest in nuclear medicine and diagnostic imaging infrastructure
- Key Drivers:
- Rising investment in healthcare facilities and imaging technologies
- Need for accurate, efficient, and safe diagnostic procedures
- Government initiatives supporting advanced diagnostic capabilities
- Trends: Increasing deployment of Tc-99m in cardiology, oncology, bone, and multi-organ imaging studies.
High Market Density and Competition
Competition is strong due to the presence of established players such as Lantheus Holdings, Curium, Jubilant Radiopharma, NorthStar Medical Radioisotopes, and NTP Radioisotopes.
This high level of competition urges companies to stand out by offering:
- High-quality, reliable tracers optimized for SPECT and hybrid imaging systems.
- Ensuring affordable, safe, and accurate imaging for cardiology, oncology, bone, and other clinical applications.
- Partnering with healthcare providers and imaging system manufacturers to improve adoption, clinical support, and workflow efficiency.
Opportunities and Strategic Moves
- Working closely with hospitals, testing centers, and imaging equipment providers will be important for getting more people to use Tc-99m and making sure it fits smoothly into daily work.
- Investment in advanced radiopharmaceutical development and production capabilities helps deliver reliable, high-quality Tc-99m solutions for diverse diagnostic applications.
- Adoption of modular and scalable imaging protocols and tracer kits enables flexible deployment across cardiology, oncology, bone, and multi-organ diagnostic procedures.
- Lantheus Announces Sale of SPECT Business to SHINE Technologies - Lantheus Holdings, Inc announced a definitive agreement to sell its single photon emission computed tomography (SPECT) business to Illuminated Holdings, Inc., the parent company of SHINE Technologies, LLC (collectively, “SHINE”). Under the terms of the agreement, SHINE will acquire Lantheus’ SPECT business, including its diagnostic agents (TechneLite (Technetium Tc 99m generator), NEUROLITE (Kit for the Preparation of Technetium Tc 99m Bicisate for Injection), Xenon Xe-133 Gas (Xenon Xe-133 Gas), and Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), the portion of the North Billerica, Massachusetts campus that manufactures Lantheus’ SPECT products, and the SPECT-related Canadian operations.
- Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals - NRG PALLAS and Curium have extended their collaboration to produce molybdenum-99through a new multi-year agreement. Molybdenum-99, which transforms into technetium-99, is a critical isotope used in nuclear medicine. This agreement underlines the shared dedication of both partners to a stable and uninterrupted supply of technetium-99m for patient care worldwide.
The "Technetium-99m Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Technetium-99m Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Technetium-99m Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Technetium-99m Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Technetium-99m Market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Application Area, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
As of 2025:1. Asia Pacific: The Technetium-99m market is growing rapidly in Asia Pacific due to expanding healthcare infrastructure, rising adoption of nuclear medicine, and government support for early disease detection. Countries such as China, India, Japan, and South Korea are driving demand with increasing investments in hospitals, diagnostic centers, and advanced imaging technologies.2. Europe: Europe benefits from well-established healthcare systems, rising aging populations, and a focus on preventive diagnostics. Growing demand from hospitals and imaging centers, along with investments in hybrid SPECT/CT and high-efficiency Tc-99m radiopharmaceuticals, is fueling market adoption.3. North America: The North America Technetium-99m market is expanding steadily, driven by advanced healthcare infrastructure, high nuclear medicine adoption rates, and strong government initiatives promoting diagnostic imaging and early disease detection.
Key end users utilizing the Technetium-99m include:1. Hospitals: Major users of Technetium-99m for routine and specialized diagnostic imaging across multiple clinical departments.2. Diagnostic and Imaging Centers: Key adopters of Tc-99m for high-precision SPECT and hybrid imaging procedures.3. Others: Includes research institutes and mobile imaging units utilizing Tc-99m for specialized or experimental diagnostic applications.
The bone scan segment is gaining significant traction in the Technetium-99m market due to its ability to detect fractures, infections, and metastatic lesions early and accurately.
As of 2024, the global Technetium-99m market is valued at approximately USD 4.54 billion . It is projected to reach USD 6.03 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.2% during the forecast period from 2025 to 2031.
The market is primarily driven by:1. Rising Demand for Accurate and Efficient Diagnostic Imaging: The increasing need for fast, reliable medical imaging is driving widespread use of Technetium-99m in hospitals and diagnostic centres.2. Shift Toward Advanced Hybrid Imaging Systems: Growing adoption of SPECT/CT and hybrid modalities is boosting demand for Technetium-99m radiopharmaceuticals.3. Focus on Workflow Efficiency and Reduced Radiation Exposure: Technetium-99m enables quicker scans with lower radiation, improving overall imaging efficiency and patient safety.
Challenges include:Supply Chain Dependence on Mo-99: Technetium-99m production relies heavily on Molybdenum-99 supply, making the market vulnerable to reactor shortages and production disruptions.
Major players include Lantheus Holdings, Curium, Jubilant Radiopharma, NorthStar Medical Radioisotopes, and NTP Radioisotopes.
The List of Companies - Technetium-99m Market
- Lantheus Holdings Inc
- Curium
- Jubilant Radiopharma
- NorthStar Medical Radioisotopes, LLC
- Sun RadioPharma (Sun Pharmaceutical Industries, Inc.);
- NTP Radioisotopes SOC Ltd
- Cardinal Health Inc
- Medi-Radiopharma
- Eckert & Ziegler AG
- Isotope JSC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Technetium-99m Market
Dec 2025
Prenatal Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Diagnostic Type (Noninvasive and Invasive), Disease (Aneuploidy, Microdeletions, Structural Chromosomal Abnormalities, and Others), End User (Hospitals, Diagnostic Laboratories, Specialty Clinics, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Joint Resurfacing Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Knee, Hip, Shoulder, Ankle, and Others), Material (Metal, Ceramic, and Others), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America)
Dec 2025
Embolization Plugs Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Neurology, Peripheral Vascular Disease, Oncology, Urology, and Others), End User (Hospital, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Aesthetic Exosomes Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human-derived, Animal-derived, and Plant-derived), Route of Administration (Topical and Injectable), Application (Skin Rejuvenation, Wrinkle Reduction and Fine Line Correction, Scar and Pigmentation, Post-procedure Recovery, Hair Restoration, and Others), and End User (Hospitals, Dermatology Clinics, Medical Spas, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Carrier Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Other Medical Conditions), End User (Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Natural Albumin Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human Serum Albumin, Bovine Serum Albumin, and Plant Serum Albumin), Application (Therapeutic Applications, Drug Delivery, Disease Diagnostics, Research, and Others Applications), and End User (Hospitals and Clinics, Pharmaceutical and Biotechnological Companies, Research Institutes, Diagnostic Laboratories, Homecare Settings, and Others)
Dec 2025
Recombinant Albumin Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human Recombinant Albumin, Bovine Recombinant Albumin, and Others), Application (Excipient in Biotherapeutics And Vaccines, Cell Culture, Drug Delivery, Diagnostics, and Others), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Hospitals and Diagnostic Laboratories, and Others)
Dec 2025
Predictive Genetic Testing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Predispositional Testing and Presymptomatic Testing), Disease (Cancer, Cardiovascular Diseases, Metabolic Diseases, and Other Diseases), End User (Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)